A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2004
12/15/2004	CN1179646C Aggregation-preventing nano broad spectrum antibacterial silver powder and its inductrial production process
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831073 Treating postmenopausal estrogenic deficiencies without appearance of osteoporosis and/or withdrawal bleeding; continuously administering free or esterified estradiol and nomegestrol acetate
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/09/2004	WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7)
12/09/2004	WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
12/09/2004	WO2004106382A1 Antibody and use thereof
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004105788A1 UNITARY COMBINATION OF FSH AND hCG
12/09/2004	WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
12/09/2004	US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004	US20040248921 Reducing androgen levels; acne, prostate diseases, alopecia, hirsutism; such as 17-chloromethylene-4-aza-5-alpha-estran-3-one
12/09/2004	US20040248891 Imidazotriazinone-containing compositions for nasal administration
12/09/2004	US20040248870 High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
12/09/2004	US20040248784 Unitary combinations of FSH and hCG
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040247639 Topical, local, transdermal or oral administration of a secretory phospholipase A2 inhibitor; menstrual migraine and menorrhagia; improved side effect reduction compared to non-steroidal antiinflammatory agents
12/09/2004	CA2524755A1 Unitary combination of fsh and hcg
12/08/2004	EP1484332A2 Lipid-based drug delivery system for administration of a drug substance
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483237A2 Tropane compounds
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments
12/08/2004	EP1482980A1 Prostaglandin composition for the treatment of erectile dysfunction
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482949A1 Sulfatase inhibiting progestogen-only contraceptive regimens
12/08/2004	EP1482948A1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
12/08/2004	EP1482947A1 Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482925A1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl!-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
12/08/2004	EP1482920A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
12/08/2004	EP1439845A4 Inactivation of papillomavirus
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	CN1553917A 17alpha-hydroxy-14beta-steroids with hormonal effect
12/08/2004	CN1553810A Use of HCG and LH in controlled ovarian hyperstimulation
12/08/2004	CN1553809A Use of LH in controlled ovarian hyperstimulation
12/08/2004	CN1553808A Use of HCG in controlled ovarian hyperstimulation
12/08/2004	CN1552856A DNA encoding a plasminogen-activating protein
12/08/2004	CN1552714A 2-substituted benzyl-5,7-dihydrocarbyl-3,7-dihydro pyrroline [2,3-d] pyromidine-4-one derivative ,its preparation and medicinal use
12/08/2004	CN1552427A Plaster for treating tumour and tuberculosis etc. diseases
12/08/2004	CN1552422A Motherwort soft capsule and preparing method thereof
12/08/2004	CN1552413A Internal medicine for treating SARS, AIDS virus, preparing method and use thereof
12/08/2004	CN1552372A Pills against gynecologic inflammation and their preparation
12/08/2004	CN1552371A Flower red pills and their preparation
12/08/2004	CN1552368A Fuyankang pills against gynecologic inflammation and their preparation
12/08/2004	CN1552367A Menstruation regulating and face nourishing pills and their preparation
12/08/2004	CN1552366A Donkey hide gelatin and Chinese angelica nourishing blood pills and their preparation
12/08/2004	CN1552342A Medicine for preventing gynaecological disease
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178687C Compound seabuckthorn fruit oil suppository
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6827931 Method for treating endocrine disorders
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103971A1 Cyclic aminophenyl sulfamate derivative
12/02/2004	WO2004103380A1 Water-soluble isoflavone composition, process for producing the same, and use thereof
12/02/2004	WO2004103336A2 Drug delivery system
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	US20040243606 Hormonal contraceptive product
12/02/2004	US20040243316 Crystallographic structure of the androgen receptor ligand binding domain
12/02/2004	US20040242890 Agonists of beta-adrenoceptors
12/02/2004	US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242626 Nasal delivery of apomorphine
12/02/2004	US20040242625 Nasal delivery of apomorphine
12/02/2004	US20040242624 Nasal delivery of apomorphine
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242590 Pharmaceutical composition comprising gamma-butyrobetaine
12/02/2004	US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc.
12/02/2004	US20040242571 Novel benzothiazine derivatives, their preparation and use
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242550 kits containing a plurality of daily hormone units for use as antifertility agents; administering in two alternating consecutive phases of estrogenic and progestogenic phase; side effect reduction
12/02/2004	US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin
12/02/2004	US20040242506 Formed from paroxetine hydrochloride and ammonium glycyrrhyzinate by precipitation, spray, vacuum or freeze drying, or evaporation to glass; solid or oil; masks the bitter taste of paroxetine and has a distinctive licorice flavor; antidepressants; Parkinson's disease
12/02/2004	US20040242476 Peptide and analogs thereof having an amino acid sequence corresponding to the second extracellular domain of a mammalian occludin; may be administered orally or parenterally

1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 557